Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Checkpoint Therapeutics receives PIP waivers for cosibelimab from EMA » 08:33
05/13/22
05/13
08:33
05/13/22
08:33
CKPT

Checkpoint Therapeutics

$1.08 /

+0.1128 (+11.66%)

Checkpoint Therapeutics…

Checkpoint Therapeutics announced that it has received Pediatric Investigation Plan, PIP, product-specific waivers from the European Medicines Agency, EMA. and the U.K. Medicines & Healthcare products Regulatory Agency, MHRA, for cosibelimab in cutaneous squamous cell carcinoma, cSCC. Following the announcement of positive topline data from Checkpoint's registration-enabling clinical trial in January 2022, a U.S. Biologics License Application, BLA, submission for cosibelimab is planned for later this year, to be followed by marketing authorization applications, MAAs, in Europe. "These waivers from the EMA and MHRA are important milestones in the European regulatory process for cosibelimab in cSCC," said James Oliviero, President and Chief Executive Officer of Checkpoint Therapeutics. "Such PIP waivers enable us to proceed more quickly and cost-effectively when advancing our marketing approval applications with the EMA and MHRA, avoiding the significant time and expense required to conduct a pediatric clinical study in Europe. As such, these PIP waivers enhance the value of the cosibelimab program in Europe for Checkpoint and potential partners."

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

Earnings
Checkpoint Therapeutics reports Q1 EPS (20c), consensus (14c) » 16:36
05/12/22
05/12
16:36
05/12/22
16:36
CKPT

Checkpoint Therapeutics

$1.08 /

+0.1128 (+11.66%)

James F. Oliviero,…

James F. Oliviero, President and CEO of Checkpoint, said, "The positive topline results generated in the first quarter from our ongoing registrational trial of cosibelimab in metastatic cutaneous squamous cell carcinoma laid the foundation for a potentially transformational year for our lead immunotherapy product candidate and for our company as a whole. We remain on track to submit our U.S. Biologics License Application for cosibelimab later this year and continue to evaluate partnership opportunities for the potential commercialization of cosibelimab in Europe and other key territories worldwide." Mr. Oliviero continued, "Our focus remains on advancing our pipeline of potentially life-saving novel oncology therapies with the goal of expanding patient access globally through a disruptive pricing strategy, beginning with the $30 billion and growing PD-(L)1 market."

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

CKPT Checkpoint Therapeutics
$1.08 /

+0.1128 (+11.66%)

Over a month ago
Conference/Events
Checkpoint Therapeutics management to meet virtually with Lake Street » 04:55
04/12/22
04/12
04:55
04/12/22
04:55
CKPT

Checkpoint Therapeutics

$1.51 /

-0.065 (-4.14%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Lake Street.

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.51 /

-0.065 (-4.14%)

CKPT Checkpoint Therapeutics
$1.51 /

-0.065 (-4.14%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.51 /

-0.065 (-4.14%)

CKPT Checkpoint Therapeutics
$1.51 /

-0.065 (-4.14%)

Conference/Events
B. Riley to hold a virtual summit » 04:55
04/06/22
04/06
04:55
04/06/22
04:55
FBIO

Fortress Biotech

$1.50 /

+0.06 (+4.17%)

, DERM

Journey Medical

$4.95 /

-0.05 (-1.00%)

, CKPT

Checkpoint Therapeutics

$1.73 /

-0.045 (-2.54%)

, MBIO

Mustang Bio

$1.06 /

-0.07 (-6.22%)

Fortress Biotech…

Fortress Biotech Corporate Access Virtual Summit to be held on April 5-6.Webcast Link

ShowHide Related Items >><<
MBIO Mustang Bio
$1.06 /

-0.07 (-6.22%)

FBIO Fortress Biotech
$1.50 /

+0.06 (+4.17%)

DERM Journey Medical
$4.95 /

-0.05 (-1.00%)

CKPT Checkpoint Therapeutics
$1.73 /

-0.045 (-2.54%)

FBIO Fortress Biotech
$1.50 /

+0.06 (+4.17%)

10/26/21 Roth Capital
Avenue Therapeutics FDA panel positive for Fortress Biotech, says Roth Capital
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
06/17/21 B. Riley
Fortress Biotech price target lowered to $8 from $9 at B. Riley
04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
DERM Journey Medical
$4.95 /

-0.05 (-1.00%)

02/25/22 Cantor Fitzgerald
Journey Medical initiated with an Overweight at Cantor Fitzgerald
01/13/22 Roth Capital
Roth raises Journey Medical target to $17 after dermatology assets acquisition
12/16/21 Roth Capital
Journey Medical initiated with a Buy at Roth Capital
12/07/21 B. Riley
Journey Medical initiated with Buy, $14 target at B. Riley
CKPT Checkpoint Therapeutics
$1.73 /

-0.045 (-2.54%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
MBIO Mustang Bio
$1.06 /

-0.07 (-6.22%)

01/24/22 B. Riley
Mustang Bio price target lowered to $6 from $13 at B. Riley
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
MBIO Mustang Bio
$1.06 /

-0.07 (-6.22%)

FBIO Fortress Biotech
$1.50 /

+0.06 (+4.17%)

DERM Journey Medical
$4.95 /

-0.05 (-1.00%)

CKPT Checkpoint Therapeutics
$1.73 /

-0.045 (-2.54%)

  • 12
    Nov
FBIO Fortress Biotech
$1.50 /

+0.06 (+4.17%)

DERM Journey Medical
$4.95 /

-0.05 (-1.00%)

CKPT Checkpoint Therapeutics
$1.73 /

-0.045 (-2.54%)

Conference/Events
B. Riley to hold a virtual summit » 10:32
04/05/22
04/05
10:32
04/05/22
10:32
FBIO

Fortress Biotech

$1.46 /

+0.02 (+1.39%)

, DERM

Journey Medical

$5.13 /

+0.13 (+2.60%)

, CKPT

Checkpoint Therapeutics

$1.74 /

-0.03 (-1.69%)

, MBIO

Mustang Bio

$1.08 /

-0.05 (-4.44%)

Fortress Biotech…

Fortress Biotech Corporate Access Virtual Summit to be held on April 5-6.Webcast Link

ShowHide Related Items >><<
MBIO Mustang Bio
$1.08 /

-0.05 (-4.44%)

FBIO Fortress Biotech
$1.46 /

+0.02 (+1.39%)

DERM Journey Medical
$5.13 /

+0.13 (+2.60%)

CKPT Checkpoint Therapeutics
$1.74 /

-0.03 (-1.69%)

FBIO Fortress Biotech
$1.46 /

+0.02 (+1.39%)

10/26/21 Roth Capital
Avenue Therapeutics FDA panel positive for Fortress Biotech, says Roth Capital
09/29/21 H.C. Wainwright
H.C. Wainwright says Astra deal for Caelum to yield 'nice check' for Fortress
06/17/21 B. Riley
Fortress Biotech price target lowered to $8 from $9 at B. Riley
04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
DERM Journey Medical
$5.13 /

+0.13 (+2.60%)

02/25/22 Cantor Fitzgerald
Journey Medical initiated with an Overweight at Cantor Fitzgerald
01/13/22 Roth Capital
Roth raises Journey Medical target to $17 after dermatology assets acquisition
12/16/21 Roth Capital
Journey Medical initiated with a Buy at Roth Capital
12/07/21 B. Riley
Journey Medical initiated with Buy, $14 target at B. Riley
CKPT Checkpoint Therapeutics
$1.74 /

-0.03 (-1.69%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
MBIO Mustang Bio
$1.08 /

-0.05 (-4.44%)

01/24/22 B. Riley
Mustang Bio price target lowered to $6 from $13 at B. Riley
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
MBIO Mustang Bio
$1.08 /

-0.05 (-4.44%)

FBIO Fortress Biotech
$1.46 /

+0.02 (+1.39%)

DERM Journey Medical
$5.13 /

+0.13 (+2.60%)

CKPT Checkpoint Therapeutics
$1.74 /

-0.03 (-1.69%)

  • 12
    Nov
FBIO Fortress Biotech
$1.46 /

+0.02 (+1.39%)

DERM Journey Medical
$5.13 /

+0.13 (+2.60%)

CKPT Checkpoint Therapeutics
$1.74 /

-0.03 (-1.69%)

Conference/Events
Checkpoint Therapeutics management to meet virtually with Lake Street » 07:01
04/05/22
04/05
07:01
04/05/22
07:01
CKPT

Checkpoint Therapeutics

$1.77 /

-0.005 (-0.28%)

Virtual Meeting to be…

Virtual Meeting to be held on April 12 hosted by Lake Street.

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

Conference/Events
Checkpoint Therapeutics management to meet virtually with Cantor Fitzgerald » 05:55
04/05/22
04/05
05:55
04/05/22
05:55
CKPT

Checkpoint Therapeutics

$1.77 /

-0.005 (-0.28%)

Virtual Meetings to be…

Virtual Meetings to be held April 4-5 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.005 (-0.28%)

Conference/Events
Checkpoint Therapeutics management to meet virtually with Cantor Fitzgerald » 04:55
04/04/22
04/04
04:55
04/04/22
04:55
CKPT

Checkpoint Therapeutics

$1.78 /

+0.005 (+0.28%)

Virtual Meetings to be…

Virtual Meetings to be held April 4-5 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.78 /

+0.005 (+0.28%)

CKPT Checkpoint Therapeutics
$1.78 /

+0.005 (+0.28%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.78 /

+0.005 (+0.28%)

CKPT Checkpoint Therapeutics
$1.78 /

+0.005 (+0.28%)

Conference/Events
Checkpoint Therapeutics management to meet virtually with Cantor Fitzgerald » 06:09
03/31/22
03/31
06:09
03/31/22
06:09
CKPT

Checkpoint Therapeutics

$1.75 /

-0.085 (-4.63%)

Virtual Meetings to be…

Virtual Meetings to be held April 4-5 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.75 /

-0.085 (-4.63%)

CKPT Checkpoint Therapeutics
$1.75 /

-0.085 (-4.63%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.75 /

-0.085 (-4.63%)

CKPT Checkpoint Therapeutics
$1.75 /

-0.085 (-4.63%)

Earnings
Checkpoint Therapeutics reports 2021 EPS (75c), consensus (51c) » 07:32
03/28/22
03/28
07:32
03/28/22
07:32
CKPT

Checkpoint Therapeutics

$1.77 /

-0.12 (-6.35%)

Reports 2021 revenue…

Reports 2021 revenue $268,000, consensus $350,000. James Oliviero, President and CEO of Checkpoint, said, "The past year represented a truly transformational period for Checkpoint Therapeutics, with the foundation laid for multiple significant potentially value enhancing catalysts in 2022. Following the positive topline results from our ongoing registrational trial of cosibelimab in metastatic cutaneous squamous cell carcinoma announced earlier this year, we look forward to a planned Biologics License Application submission for cosibelimab later in 2022." Mr. Oliviero continued, "We remain focused on expeditiously advancing our pipeline of product candidates with the goal of expanding patient access globally to potentially life-saving novel oncology therapies through a disruptive pricing strategy."

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$1.77 /

-0.12 (-6.35%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.12 (-6.35%)

01/26/22 Ladenburg
Checkpoint Therapeutics price target raised to $26 from $20 at Ladenburg
01/26/22 Cantor Fitzgerald
Checkpoint Therapeutics price target raised to $20 from $16 at Cantor Fitzgerald
01/25/22 H.C. Wainwright
Checkpoint Therapeutics price target raised to $26 from $17 at H.C. Wainwright
06/09/21
Fly Intel: Top five analyst initiations
CKPT Checkpoint Therapeutics
$1.77 /

-0.12 (-6.35%)

CKPT Checkpoint Therapeutics
$1.77 /

-0.12 (-6.35%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.